Release Date: 30/09/16 19:17 Summary: Appendix 4G Corporate Governance Disclosure-BSP.AX Price Sensitive: No Download Document 210.29KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status